Unmet Needs in Respiratory Diseases
Identifieur interne : 001A38 ( Main/Exploration ); précédent : 001A37; suivant : 001A39Unmet Needs in Respiratory Diseases
Auteurs : Christopher Chang [États-Unis]Source :
- Clinical Reviews in Allergy & Immunology [ 1080-0549 ] ; 2013-12-01.
Descripteurs français
- Wicri :
- topic : Vaccination.
English descriptors
- KwdEn :
- Anti-neutrophil cytoplasmic antibody, Biological modulators, Churg–Strauss syndrome, Cystic fibrosis, Cystic fibrosis transmembrane conductance receptor, Gene therapy, Granulomatosus with polyangiitis, Mycobacterium tuberculosis, Pertussis, Respiratory syncytial virus, Rhinovirus, Severe acute respiratory syndrome, Tuberculosis, Vaccination, Vaccines, Wegener’s granulomatosus.
Abstract
Abstract: The care of patients with respiratory diseases has improved vastly in the past 50 years. In spite of that, there are still massive challenges that have not been resolved. Although the incidence of tuberculosis has decreased in the developed world, it is still a significant public health problem in the rest of the world. There are still over 2 million deaths annually from tuberculosis, with most of these occurring in the developing world. Even with the development of new pharmaceuticals to treat tuberculosis, there is no indication that the disease will be eradicated. Respiratory syncytial virus, severe acute respiratory syndrome, and pertussis are other respiratory infectious diseases with special problems of their own, from vaccine development to vaccine coverage. Asthma, one of the most common chronic diseases in children, still accounts for significant mortality and morbidity, as well as high health care costs worldwide. Even in developed countries such as the USA, there are over 4,000 deaths per year. Severe asthma presents a special problem, but the question is whether there can be one treatment pathway for all patients with severe asthma. Severe asthma is a heterogeneous disease with many phenotypes and endotypes. The gene for cystic fibrosis was discovered over 24 years ago. The promise of gene therapy as a cure for the disease has fizzled out, and while new antimicrobials and other pharmaceuticals promise improved longevity and better quality of life, the average life span of a patient with cystic fibrosis is still at about 35 years. What are the prospects for gene therapy in the twenty-first century? Autoimmune diseases of the lung pose a different set of challenges, including the development of biomarkers to diagnose and monitor the disease and biological modulators to treat the disease.
Url:
DOI: 10.1007/s12016-013-8399-2
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000344
- to stream Istex, to step Curation: 000344
- to stream Istex, to step Checkpoint: 000316
- to stream Main, to step Merge: 001A48
- to stream Main, to step Curation: 001A38
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unmet Needs in Respiratory Diseases</title><author><name sortKey="Chang, Christopher" sort="Chang, Christopher" uniqKey="Chang C" first="Christopher" last="Chang">Christopher Chang</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:991D0DE54A3031E2BBC85142F105776B30A8E6CF</idno><date when="2013" year="2013">2013</date><idno type="doi">10.1007/s12016-013-8399-2</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-Q92M2L5C-K/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000344</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000344</idno><idno type="wicri:Area/Istex/Curation">000344</idno><idno type="wicri:Area/Istex/Checkpoint">000316</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000316</idno><idno type="wicri:doubleKey">1080-0549:2013:Chang C:unmet:needs:in</idno><idno type="wicri:Area/Main/Merge">001A48</idno><idno type="wicri:Area/Main/Curation">001A38</idno><idno type="wicri:Area/Main/Exploration">001A38</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Unmet Needs in Respiratory Diseases</title><author><name sortKey="Chang, Christopher" sort="Chang, Christopher" uniqKey="Chang C" first="Christopher" last="Chang">Christopher Chang</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Allergy and Immunology, Thomas Jefferson University, 1600 Rockland Road, 19803, Wilmington, DE</wicri:regionArea><placeName><region type="state">Delaware</region></placeName></affiliation><affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Clinical Reviews in Allergy & Immunology</title><title level="j" type="abbrev">Clinic Rev Allerg Immunol</title><idno type="ISSN">1080-0549</idno><idno type="eISSN">1559-0267</idno><imprint><publisher>Springer US; http://www.springer-ny.com</publisher><pubPlace>Boston</pubPlace><date type="published" when="2013-12-01">2013-12-01</date><biblScope unit="volume">45</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="303">303</biblScope><biblScope unit="page" to="313">313</biblScope></imprint><idno type="ISSN">1080-0549</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1080-0549</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-neutrophil cytoplasmic antibody</term><term>Biological modulators</term><term>Churg–Strauss syndrome</term><term>Cystic fibrosis</term><term>Cystic fibrosis transmembrane conductance receptor</term><term>Gene therapy</term><term>Granulomatosus with polyangiitis</term><term>Mycobacterium tuberculosis</term><term>Pertussis</term><term>Respiratory syncytial virus</term><term>Rhinovirus</term><term>Severe acute respiratory syndrome</term><term>Tuberculosis</term><term>Vaccination</term><term>Vaccines</term><term>Wegener’s granulomatosus</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Vaccination</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: The care of patients with respiratory diseases has improved vastly in the past 50 years. In spite of that, there are still massive challenges that have not been resolved. Although the incidence of tuberculosis has decreased in the developed world, it is still a significant public health problem in the rest of the world. There are still over 2 million deaths annually from tuberculosis, with most of these occurring in the developing world. Even with the development of new pharmaceuticals to treat tuberculosis, there is no indication that the disease will be eradicated. Respiratory syncytial virus, severe acute respiratory syndrome, and pertussis are other respiratory infectious diseases with special problems of their own, from vaccine development to vaccine coverage. Asthma, one of the most common chronic diseases in children, still accounts for significant mortality and morbidity, as well as high health care costs worldwide. Even in developed countries such as the USA, there are over 4,000 deaths per year. Severe asthma presents a special problem, but the question is whether there can be one treatment pathway for all patients with severe asthma. Severe asthma is a heterogeneous disease with many phenotypes and endotypes. The gene for cystic fibrosis was discovered over 24 years ago. The promise of gene therapy as a cure for the disease has fizzled out, and while new antimicrobials and other pharmaceuticals promise improved longevity and better quality of life, the average life span of a patient with cystic fibrosis is still at about 35 years. What are the prospects for gene therapy in the twenty-first century? Autoimmune diseases of the lung pose a different set of challenges, including the development of biomarkers to diagnose and monitor the disease and biological modulators to treat the disease.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Delaware</li></region></list><tree><country name="États-Unis"><region name="Delaware"><name sortKey="Chang, Christopher" sort="Chang, Christopher" uniqKey="Chang C" first="Christopher" last="Chang">Christopher Chang</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001A38 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001A38 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:991D0DE54A3031E2BBC85142F105776B30A8E6CF
|texte= Unmet Needs in Respiratory Diseases
}}
| This area was generated with Dilib version V0.6.33. |  |